USPTO serial 79153260
Reviewed by CopyMark Law Group
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lori A. Ruhly
Lori A. Ruhly Quarles & Brady LLP33 East Main Street, Suite 900Madison, WI 53703United States| Class | Description | Status | First use |
|---|---|---|---|
| 001 | [ Chemicals for use in the pharmaceutical industry; chemical substances for preserving foodstuffs; chemicals for use in the manufacture of pharmaceuticals for the treatment of angiologic disorders, particularly varicose veins; chemicals for use in the production of injectable foams ] | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical preparations for the treatment of varicose veins and arterio-venous malformations; pharmaceutical preparations for the treatment of vascular diseases; pharmaceutical products and preparations to prevent swelling in the legs; sanitary preparations for medical purposes; [ dietary supplements for humans and animals; medical plasters; materials for dressings, namely, adhesives bandages, medical and surgical adhesive tape; ] medical dressings; surgical dressings; wound dressings; pharmaceutical preparations in the form of foams and for use in preparing foams, for sclerotherapy, phlebology, angiology, [ and proctology, for treatment of oesophageal varices, hydroceles, ] in sterilization treatment and for treatment of varicose veins, and arterio-venous malformations | ACTIVE | — |
| 010 | Surgical and medical apparatus for use in the treatment of varicose veins, arterio-venous malformation, [ oesophageal varices and hydroceles; ] surgical and medical apparatus for use in sclerotherapy, phlebology, angiology, [ and proctology, and for the treatment of oesophageal varices, hydroceles, ] in sterilization treatment and for the treatment of varicose veins, and arterio-venous malformations; medical syringes; [ cannula needles for medical use; ] medical tubing for sclerotherapy; medical tubing for treatment of varicose veins, venose malformations, arterio-venous malformations, [ oesophageal varices and hydroceles; ] surgical and medical apparatus for producing and administering foams for the treatment of varicose veins, venous malformations, arterio-venous malformations, [ oesophageal varices and hydroceles; ] surgical and medical apparatus for producing and administering foams for use in sterilization treatment; surgical and medical apparatus for producing foams for use in sclerotherapy, phlebology, angiology [ and proctology, ] sterilization treatment and for treatment of varicose veins, arterio-venous malformations, [ oesophageal varices and hydroceles; ] none of the aforementioned goods being supportive bandages or compression bandages; medical devices, namely, devices for assessing the physical characteristics of foams for use in sclerotherapy, phlebology, angiology [ and proctology, ] sterilization treatment and for treatment of varicose veins, arterio-venous malformations, [ oesophageal varices and hydroceles, ] devices for intravenous administration of such foam [ and devices for monitoring the position and effect of such foam in the human body; medical diagnostic devices for use in all the above medical conditions ] | ACTIVE | — |
| 042 | [ Design and development of computer hardware and software; computer programming; installation, maintenance and repair of computer software; computer consultancy services; scientific research services related to sclerotherapy of veins including provision of treatment in the fields of phlebology, proctology and angiology ] | SECTION 71 - CANCELLED | — |
| 044 | [ Medical services; hygienic and beauty care for human beings or animals; medical analysis for the diagnosis and treatment of persons in the fields of sclerotherapy, phlebology, angiology and proctology and in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment; pharmaceutical advice; medical services for diagnosis in the fields of sclerotherapy, phlebology, angiology and proctology and, in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment; medical health assessment services, namely, providing post-treatment and homecare to patients in the fields of sclerotherapy, phlebology, angiology and proctology and, in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment; medical treatment services in the fields of sclerotherapy, phlebology, angiology and proctology and, in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment; medical after-care services in the fields of sclerotherapy, phlebology, angiology and proctology and, in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment ] | SECTION 71 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| May 10, 2026 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| May 10, 2026 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| May 4, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jan 15, 2026 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Mar 15, 2025 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Dec 13, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 3, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 3, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 3, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 3, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 26, 2024 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Jun 28, 2024 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Sep 23, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 11, 2023 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Jul 23, 2023 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jul 23, 2023 | INPC | INVALIDATION PROCESSED | — |
| Jun 19, 2023 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| May 22, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 22, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 22, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 22, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 22, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 19, 2022 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Oct 19, 2022 | C75P | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Oct 18, 2022 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Sep 15, 2022 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Jan 8, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 15, 2021 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 13, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 8, 2016 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 17, 2016 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 17, 2016 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 15, 2016 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 15, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 31, 2015 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 29, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 29, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 9, 2015 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 9, 2015 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 9, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 23, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 21, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 19, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 18, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 18, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 19, 2015 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| May 19, 2015 | LIME | LIMITATION FROM THE IB - REQUEST EXAM REVIEW | — |
| May 19, 2015 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| May 18, 2015 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 17, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 12, 2015 | ALIE | ASSIGNED TO LIE | — |
| May 1, 2015 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| May 1, 2015 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Apr 24, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 23, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 23, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 14, 2014 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 27, 2014 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 27, 2014 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 25, 2014 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 24, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 21, 2014 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 17, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 17, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 16, 2014 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |